Image de couverture de livre

No Effect of Low‐Dose Aspirin Versus Placebo as Add‐On Treatment in Bipolar Disorder—Results From a Randomised Controlled Trial (the A‐Bipolar RCT )

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Sharaz Ahmed, Shubha Bagri, Nishtha Chawla
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	Acta Psychiatrica Scandinavica
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Correction to “Is a Vegetarian Diet Beneficial for Bipolar Disorder? Relationship Between Dietary Patterns, Exercise and Pharmacological Treatments With Metabolic Syndrome and Course of Disease in Bipolar Disorder”
Publié: (2025)

Seasonality Patterns in Bipolar Disorder: Associations With Clinical Phenotypes and Treatment‐Related Outcomes
par: Siralp Bostan, et autres
Publié: (2025)

Diagnostic Conversion From Psychotic Unipolar Depression to Bipolar and Psychotic Disorders: A Swedish Registry‐Based Study
par: Ahmed Al‐Wandi, et autres
Publié: (2025)

Family History and Solar Insolation in Bipolar I Disorder
par: M. Bauer, et autres
Publié: (2026)

Bipolar Disorder and Poisoning due to Medicines or Illegal Substances
par: Mikko Niskanen, et autres
Publié: (2025)

Lifetime Mixed Depression and Childhood Trauma in Individuals With Bipolar Disorders
par: Francesca Bardi, et autres
Publié: (2026)

Childhood Maltreatment and Cognitive Performance in Bipolar Disorder: The Potential Role of Inflammation
par: Marzieh Majd, et autres
Publié: (2025)

Estimating Cognitive Impairment in Bipolar Disorder: Should We Account for Premorbid IQ ?
par: Dimosthenis Tsapekos, et autres
Publié: (2025)

Childhood Maltreatment and Cognitive Functioning in Bipolar Disorder: A Systematic Review and Meta‐Analysis
par: Natalia E. Fares‐Otero, et autres
Publié: (2025)

In the Assessment of Childhood Maltreatment and Cognitive Function in Bipolar Disorder All Variables Should Be Taken Into Consideration
par: Amanda Medeiros Fernandes, et autres
Publié: (2025)

Association Between Inflammatory Markers and Cognitive Function in Adults With Bipolar Disorder: A Systematic Review
par: David R. A. Coelho, et autres
Publié: (2025)

Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar Disorders
par: Kamilla W. Miskowiak, et autres
Publié: (2025)

Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects
par: Mao‐Hsuan Huang, et autres
Publié: (2025)

Psychotic Features in Unipolar and Bipolar Depression: Commentary
par: Ross J. Baldessarini, et autres
Publié: (2026)

Switching concerns: Bipolar disorder and the antidepressant dilemma
par: René Ernst Nielsen
Publié: (2024)

Treatment of Early‐Onset Specified and Unspecified Bipolar Disorders: A Systematic Review and Strategies for Identifying and Managing a Thermally Dysregulated Subtype in Children
par: Demitri F. Papolos, et autres
Publié: (2025)

Unravelling the Link Between Body Mass Index and Cognitive Performance in Individuals With Bipolar Disorder and Exploration of PRS Moderation Effect: Findings From the PsyCourse Study
par: B. Solé, et autres
Publié: (2025)

Association Between Accelerated Atherosclerosis and High‐Sensitivity C‐Reactive Protein Levels in Bipolar Disorder and Schizophrenia
par: Shang‐Ying Tsai, et autres
Publié: (2026)

Response to: “In the Assessment of Childhood Maltreatment and Cognitive Function in Bipolar Disorder All Variables Should be Taken Into Consideration”
par: Natalia E. Fares‐Otero, et autres
Publié: (2025)

Correction to “In the Assessment of Childhood Maltreatment and Cognitive Function in Bipolar Disorder All Variables Should Be Taken Into Consideration”
Publié: (2025)

Internet‐Based Cognitive Assessments During Remission in Bipolar Disorder: Subjective Cognitive Function and Clinical Severity
par: Kristin Svee, et autres
Publié: (2025)

Life Expectancy, Loss of Life Expectancy, and Lifetime Costs in Bipolar Disorder: A Nationwide Population‐Based Study
par: Ikbal Andrian Malau, et autres
Publié: (2025)

Predicting Response to Pro‐Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force
par: Dimosthenis Tsapekos, et autres
Publié: (2025)

Relationships of Cognitive Function With Subsequent Device‐Measured Physical Activity and Sedentary Time in Healthy Individuals and Those With Bipolar Disorder: Findings From the UK Biobank
par: Elysha Ringin, et autres
Publié: (2025)

Association Between Metabolic Syndrome, Obesity, and Cognitive Performances in Individuals With Bipolar Disorders: Cross‐Sectional and Longitudinal Analyses in the FACE ‐ BD Cohort
par: I. Palimaru, et autres
Publié: (2025)

The Role of Antipsychotics and Mood Stabilizers in Preventing Sickness Absence Among Employed Individuals With Bipolar Disorder: A Nationwide Register‐Based Study
par: Minna Holm, et autres
Publié: (2025)

Antidepressant Remission and Manic Switch in Bipolar Depression: A Propensity Score Analysis
par: Paul A. Vöhringer, et autres
Publié: (2025)

Psychotic Symptoms in Unipolar and Bipolar Depression and Their Impact on Disease Prognosis: A Systematic Review
par: Helena Andreu, et autres
Publié: (2026)

Correction to “A Double‐Blind, Placebo‐Controlled Trial of Rosiglitazone for Clozapine‐Induced Glucose Metabolism Impairment in Patients with Schizophrenia”
Publié: (2025)

Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis
par: Vikas Menon, et autres
Publié: (2024)

Predicting Cognitive Change During Treatment for Inpatient Depression: Secondary Analysis From a Randomized Controlled Trial
par: Zoe A. Odering, et autres
Publié: (2025)

Neural Correlates of Cognitive Improvement After Virtual Reality‐Based Cognitive Remediation in Psychosis and Mood Disorders: A Randomized Controlled Trial
par: Viktoria Damgaard, et autres
Publié: (2025)

Efficacy and Acceptability of Licensed and Off‐Label Pharmacological Interventions for Insomnia in Patients With Severe Mental Illness: A Systematic Review and Meta‐Analysis of Randomised Trials
par: Nina Friis Bak Fuglsang, et autres
Publié: (2025)

Formulating Cognitive Functioning to Guide Personalised Treatment for People Diagnosed With Mental Disorders
par: Kelly Allott, et autres
Publié: (2025)

Expanding the Utilization of Pharmacological Treatments for Alcohol Use Disorder: Reflections on a Swedish Nationwide Study
par: Szu‐Chieh Chiu, et autres
Publié: (2025)

Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol‐Related Hospitalizations: A Register Study
par: Patrick Bach, et autres
Publié: (2025)

The Effectiveness of Immersive Virtual Reality‐Based Treatment for Mental Disorders: A Systematic Review With Meta‐Analysis
par: Fatime Zeka, et autres
Publié: (2024)

The Higher Dose‐Adjusted Clozapine Concentrations in Non‐Smokers With High CRP Levels May Be Associated With the Lower Daily Doses of Clozapine
par: Yuki Kikuchi
Publié: (2025)

Cardiovascular Risk Predicts White Matter Hyperintensities, Brain Atrophy and Treatment Resistance in Major Depressive Disorder: Role of Genetic Liability
par: Marco Paolini, et autres
Publié: (2025)

Use of Attention Deficit Hyperactivity Disorder Medication Among Danish Children and Adolescents From 2010 to 2023
par: Maria Højgaard Stoltz‐Andersen, et autres
Publié: (2026)